COVID-19 associated coagulopathy: Thrombosis, hemorrhage and mortality rates with an escalated-dose thromboprophylaxis strategy.

Daughety, Molly M; Morgan, Andrew; Frost, Erin; Kao, Chester; Hwang, Joyce; Tobin, Rachel; Patel, Bhavik; Fuller, Matthew; Welsby, Ian; Ortel, Thomas L

Daughety, Molly M; Morgan, Andrew; Frost, Erin; Kao, Chester; Hwang, Joyce; Tobin, Rachel; Patel, Bhavik; Fuller, Matthew; Welsby, Ian; Ortel, Thomas L.

Daughety MM; Division of Hematology, Department of Medicine, Duke University Medical Center, Durham, NC, USA.
Morgan A; Department of Pediatrics, Duke University Medical Center, Durham, NC, USA; Department of Medicine, Duke University Medical Center, Durham, NC, USA.
Frost E; Department of Pediatrics, Duke University Medical Center, Durham, NC, USA; Department of Medicine, Duke University Medical Center, Durham, NC, USA.
Kao C; Department of Medicine, Duke University Medical Center, Durham, NC, USA.
Hwang J; Department of Medicine, Duke University Medical Center, Durham, NC, USA.
Tobin R; Department of Medicine, Duke University Medical Center, Durham, NC, USA.
Patel B; Department of Medicine, Duke University Medical Center, Durham, NC, USA.
Fuller M; Department of Anesthesiology, Duke University Medical Center, Durham, NC, USA.
Welsby I; Department of Anesthesiology, Duke University Medical Center, Durham, NC, USA.
Ortel TL; Division of Hematology, Department of Medicine, Duke University Medical Center, Durham, NC, USA; Department of Pathology, Duke University Medical Center, Durham, NC, USA. Electronic address: thomas.ortel@duke.edu.

Thromb Res ; 196: 483-485, 2020 12.

Article in English | MEDLINE | ID: covidwho-865052

Subject(s)

Anticoagulants/administration & dosage; COVID-19 Drug Treatment; Thrombosis/prevention & control; Venous Thromboembolism/prevention & control; Aged; Aged, 80 and over; Anticoagulants/adverse effects; COVID-19/complications; COVID-19/diagnosis; COVID-19/mortality; Female; Hemorrhage/chemically induced; Humans; Male; Middle Aged; Retrospective Studies; Risk Assessment; Risk Factors; Thrombosis/diagnosis; Thrombosis/etiology; Thrombosis/mortality; Time Factors; Treatment Outcome; Venous Thromboembolism/diagnosis; Venous Thromboembolism/etiology; Venous Thromboembolism/mortality

Keywords

Anticoagulation; COVID; Escalated-dose; Hemorrhage; Thromboembolism; Thromboprophylaxis; VTE

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Thrombosis / Venous Thromboembolism / COVID-19 Drug Treatment / Anticoagulants Type of study: Diagnostic study / Observational study / Prognostic study Topics: Long Covid Limits: Aged / Female / Humans / Male / Middle aged Language: English Journal: Thromb Res Year: 2020 Document Type: Article Affiliation country: J.thromres.2020.10.004

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google